MoneyWorks4Me

Astrazeneca Pharma I - Quaterly Results

13 Nov 2024 Evaluate
The sales figure stood at Rs. 4080.00 millions for the September 2024 quarter. The mentioned figure indicates a growth of about 31.16% as compared to Rs. 3110.70 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 384.30  millions from Rs. 523.70 millions ,decline by -26.62%.Operating profit for the quarter ended September 2024 decreased to 606.90 millions as compared to 611.30 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 4080.00 3110.70 31.16 7955.20 6065.40 31.16 12955.28 10029.71 29.17
Other Income 81.50 83.70 -2.63 165.00 164.70 0.18 348.00 261.02 33.32
PBIDT 606.90 611.30 -0.72 1071.10 1364.70 -21.51 2192.52 1912.27 14.66
Interest 3.40 5.00 -32.00 4.50 6.50 -30.77 12.01 6.33 89.73
PBDT 603.50 770.60 -21.68 491.00 1522.50 -67.75 2344.77 1503.65 55.94
Depreciation 93.20 36.80 153.26 132.30 74.70 77.11 149.40 162.60 -8.12
PBT 510.30 733.80 -30.46 358.70 1447.80 -75.22 2195.37 1341.05 63.71
TAX 126.00 210.10 -40.03 92.30 385.50 -76.06 580.28 348.12 66.69
Deferred Tax -21.00 -2.80 650.00 -162.20 -2.10 7623.81 -9.03 -34.90 -74.13
PAT 384.30 523.70 -26.62 266.40 1062.30 -74.92 1615.09 992.93 62.66
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 14.88 19.65 -24.31 13.46 22.50 -40.16 16.92 19.07 -11.24
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..